Avalo Therapeutics (AVTX) FCF Margin (2016 - 2026)
Avalo Therapeutics' FCF Margin came in at -24216.95% for Q4 2025, down 16381.53 percentage points from -7835.42% a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) FCF Margin (2016 - 2026) Analysis & Trends
For FY2025, Avalo Therapeutics' FCF Margin was -87288.14%, down 76164.33 percentage points from FY2024.
- FCF Margin has declined in each of the last three years, with a five-year change of -86682.05 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -11123.81% in FY2024 (-9521.00 pp), -1602.81% in FY2023 (-1454.08 pp), -148.72% in FY2022 (+1166.67 pp) and -1315.39% in FY2021 (-709.30 pp).
- The Q4 2025 figure represents the lowest quarterly FCF Margin in data going back to Q3 2016.
- The fastest year-over-year change in FCF Margin over five years came in Q4 2022 (a gain of 7373.05 percentage points), and the weakest in Q4 2025 (a drop of 16381.53 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,148.13 Bn | 1,116.72 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 630.09 Bn | 548.62 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 498.99 Bn | 472.10 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 374.92 Bn | 329.30 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 300.99 Bn | 264.98 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 264.63 Bn | 238.32 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 239.15 Bn | 194.55 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 192.23 Bn | 166.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.01% |
| 10 | Avalo Therapeutics | 317.20 Mn | -375.02 Mn | - | -724.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -724.38% |
| Mar 31, 2026 | -2,204.23% |
| Dec 31, 2025 | -24,216.95% |
| Jun 30, 2025 | -1,038.29% |
| Mar 31, 2025 | -823.78% |
| Dec 31, 2024 | -7,835.42% |
| Sep 30, 2024 | -4,629.32% |
| Dec 31, 2023 | -484.41% |
| Sep 30, 2023 | -2,896.61% |
| Jun 30, 2023 | -1,714.77% |
| Mar 31, 2023 | -2,149.47% |
| Dec 31, 2022 | -439.73% |
| Sep 30, 2022 | 38.04% |
| Jun 30, 2022 | -1,212.58% |
| Mar 31, 2022 | -1,369.74% |
| Dec 31, 2021 | -7,812.79% |
| Sep 30, 2021 | -1,212.67% |
| Jun 30, 2021 | -571.89% |
| Mar 31, 2021 | -3,876.74% |
| Dec 31, 2020 | -960.25% |
API Access
Avalo Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();